These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22841796)

  • 1. Induction of potent CD8⁺ T cell responses through the delivery of subunit protein vaccines to skin antigen-presenting cells using densely packed microprojection arrays.
    Ng HI; Fernando GJ; Kendall MA
    J Control Release; 2012 Sep; 162(3):477-84. PubMed ID: 22841796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses.
    Fernando GJ; Chen X; Primiero CA; Yukiko SR; Fairmaid EJ; Corbett HJ; Frazer IH; Brown LE; Kendall MA
    J Control Release; 2012 Apr; 159(2):215-21. PubMed ID: 22306334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses.
    Fernando GJ; Zhang J; Ng HI; Haigh OL; Yukiko SR; Kendall MA
    J Control Release; 2016 Sep; 237():35-41. PubMed ID: 27381247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
    Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
    J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection.
    Kang TH; Monie A; Wu LS; Pang X; Hung CF; Wu TC
    Vaccine; 2011 Jan; 29(5):1082-9. PubMed ID: 21130752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo.
    Powell TJ; Palath N; DeRome ME; Tang J; Jacobs A; Boyd JG
    Vaccine; 2011 Jan; 29(3):558-69. PubMed ID: 20951665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization.
    Chen X; Fernando GJ; Crichton ML; Flaim C; Yukiko SR; Fairmaid EJ; Corbett HJ; Primiero CA; Ansaldo AB; Frazer IH; Brown LE; Kendall MA
    J Control Release; 2011 Jun; 152(3):349-55. PubMed ID: 21371510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy.
    Mo A; Musselli C; Chen H; Pappas J; Leclair K; Liu A; Chicz RM; Truneh A; Monks S; Levey DL; Srivastava PK
    Vaccine; 2011 Nov; 29(47):8530-41. PubMed ID: 21767588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides.
    Inoue J; Aramaki Y
    Vaccine; 2007 Jan; 25(6):1007-13. PubMed ID: 17049678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice.
    Liu Y; Luo X; Yang C; Yu S; Xu H
    Vaccine; 2011 Aug; 29(34):5778-84. PubMed ID: 21664398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity.
    Standley SM; Mende I; Goh SL; Kwon YJ; Beaudette TT; Engleman EG; Fréchet JM
    Bioconjug Chem; 2007; 18(1):77-83. PubMed ID: 17226959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation.
    Rattanakiat S; Nishikawa M; Takakura Y
    Eur J Pharm Sci; 2012 Sep; 47(2):352-8. PubMed ID: 22771546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
    Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
    Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
    Jiang JQ; Patrick A; Moss RB; Rosenthal KL
    J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR vaccines against T cell lymphoma: QS-21 and IL-12 adjuvants induce a protective CD8+ T cell response.
    Wong CP; Okada CY; Levy R
    J Immunol; 1999 Feb; 162(4):2251-8. PubMed ID: 9973501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems.
    Gordon S; Young K; Wilson R; Rizwan S; Kemp R; Rades T; Hook S
    J Liposome Res; 2012 Sep; 22(3):193-204. PubMed ID: 22188610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending antigen release from particulate vaccines results in enhanced antitumor immune response.
    Kapadia CH; Tian S; Perry JL; Sailer D; Christopher Luft J; DeSimone JM
    J Control Release; 2018 Jan; 269():393-404. PubMed ID: 29146244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L; Kedl R; Dow S
    Cancer Gene Ther; 2006 Nov; 13(11):1033-44. PubMed ID: 16841080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs.
    Sugauchi F; Wang RY; Qiu Q; Jin B; Alter HJ; Shih JW
    J Infect Dis; 2006 Feb; 193(4):563-72. PubMed ID: 16425136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C).
    Wick DA; Martin SD; Nelson BH; Webb JR
    Vaccine; 2011 Jan; 29(5):984-93. PubMed ID: 21115055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.